Association of polymorphisms in genes regulating the corticotropin- releasing factor system with antidepressant treatment response

Archives of General Psychiatry

Volumn 67, Issue 4, 2010, Pages 369-379

  Binder, Elisabeth B ^a,b   Owens, Michael J ^b   Liu, Wei ^b,c,d   Deveau, Todd C ^b   Rush, A John ^e,f   Trivedi, Madhukar H ^e,f   Fava, Maurizio ^g   Bradley, Bekh ^b,h   Ressler, Kerry J ^b,i,j   Nemeroff, Charles B ^k  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b Department of Human Genetics ^*  (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^e UNIVERSITY OF TEXAS AT DALLAS   (United States)

^f DUKE NUS MEDICAL SCHOOL   (Singapore)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h ATLANTA VA MEDICAL CENTER   (United States)

ⁱ EMORY UNIVERSITY   (United States)

^j HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^k UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; ARGIPRESSIN RECEPTOR; ARGIPRESSIN RECEPTOR 1A; ARGIPRESSIN RECEPTOR 1B; BINDING PROTEIN; CITALOPRAM; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CORTICOTROPIN RELEASING HORMONE BINDING PROTEIN; DEXAMETHASONE; DNA; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN II; UROCORTIN III;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; ETHNIC DIFFERENCE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MENTAL HOSPITAL; NUCLEOTIDE SEQUENCE; OUTPATIENT DEPARTMENT; PHARMACOGENETICS; PHENOTYPE; RACE DIFFERENCE; REMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; TREATMENT RESPONSE;

AFRICAN AMERICANS; ALLELES; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CARRIER PROTEINS; CITALOPRAM; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; GENES; GENETIC ASSOCIATION STUDIES; GENOTYPE; HISPANIC AMERICANS; HUMANS; HYDROCORTISONE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, VASOPRESSIN;

EID: 77950553718     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2010.18     Document Type: Article

References (51)

1. Nemeroff CB. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry. 1996;1(4):336-342.
2. Nemeroff CB, Owens MJ. Treatment of mood disorders. Nat Neurosci. 2002; 5(suppl):1068-1070.
3. Keck ME. Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Amino Acids. 2006;31(3):241-250.
4. Bissette G, Klimek V, Pan J, Stockmeier C, Ordway G. Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology. 2003;28(7):1328-1335. (Pubitemid 41070903)
5. Purba JS, Hoogendijk WJ, Hofman MA, Swaab DF. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry. 1996;53(2):137-143.
6. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 1994; 60(4):436-444.
7. Merali Z, Kent P, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Bedard T, Anisman H. Corticotropin-releasing hormone, arginine vasopressin, gastrinreleasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol Psychiatry. 2006;59(7):594-602. (Pubitemid 43357953)
8. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry. 1988;45(6):577-579.
9. NemeroffCB,WideriovE,BissetteG,WalleusH,KarlssonI,EklundK,KiltsCD, LoosenPT,ValeW.ElevatedconcentrationsofCSFcorticotropin- releasingfactorlikeimmunoreactivityindepressedpatients.Science.1984;226(4680): 1342-1344.(Pubitemid15215592)
10. BankiCM,BissetteG,AratoM,O'ConnorL,NemeroffCB. CSFcorticotropinreleasingfactor- likeimmunoreactivityindepressionandschizophrenia.AmJPsychiatry.1987;144(7): 873-877.(Pubitemid17095723)
11. de Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6(6):463-475.
12. HolsboerF.CRHR1antagonistsasnoveltreatmentstrategies.CNSSpectr.2001;6(7): 590-594.(Pubitemid32816526)
13. Wideriov E, Bissette G, Nemeroff CB. Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients. J Affect Disord. 1988;14(2):99-107. (Pubitemid 18060246)
14. De Bellis MD, Gold PW, Geracioti TD Jr, Listwak SJ, Kling MA. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropinreleasing hormone and arginine vasopressin in patients with major depression. Am J Psychiatry. 1993;150(4):656-657.
15. Kling MA, Geracioti TD, Licínio J, Michelson D, Oldfield EH, Gold PW. Effects of electroconvulsive therapy on the CRH-ACTH-cortisol system in melancholic depression: preliminary findings. Psychopharmacol Bull. 1994;30(3):489-494.
16. Nemeroff CB, Bissette G, Akil H, Fink M. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy: corticotrophin-releasing factor, beta-endorphin and somatostatin. Br JPsychiatry. 1991;158:59-63.
17. HeuserIJ,SchweigerU,GotthardtU,SchmiderJ,LammersCH,DettlingM, YassouridisA,HolsboerF.Pituitary-adrenal- systemregulationandpsychopathologyduringamibiptylinetreatmentinelderlydepress edpatientsandnormalcomparisonsubjects.AmJPsychiatry.1996;153(1):93-99. (Pubitemid26026163)
18. lsing M, Kunzel HE, Binder EB, Nickel T, Modell S, Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(6):1085-1093.
19. Zobel AW, Nickel T, Kunzel HE, Ackl N, Sonntag A, lsing M, Holsboer F. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatr Res. 2000:34 (3):171-181. (Pubitemid 30364916)
20. Binneman B, Feltner D, Kolluri S, Shi Y, Qiu R, Stiger T. A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression. Am J Psychiatry. 2008;165(5):617-620. (Pubitemid 351705339)
21. Licinio J, O'Kirwan F, Irizarry K, Merriman B, Thakur S, Jepson R, Lake S, Tantisira KG, Weiss ST, Wong ML. Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans. Mol sych'ratry. 2004;9(12):1075-1082. (Pubitemid 40065452)
22. Liu Z, Zhu F, Wang G, Xiao Z, Tang J, Liu W, Wang H, Liu H, Wang X, Wu Y, Cao Z, Li W. Association study of corticotropin-releasing hormone receptorl gene polymorphisms and antidepressant response in major depressive disorders. Neurosci Lett 2007;414(2):155-158. (Pubitemid 46273990)
23. Binder EB, Salyakina D, Lichtner P, Wochnik GM, lsing M, Putz B, Papiol S, Seaman S, Lucae S, Kohli MA, Nickel T, Kunzel HE, Fuchs B, Majer M, Pfennig A, Kern N, Brunner J, Modell S, Baghai T, Deiml T, Zill, Bondy B, Rupprecht R, Messer T, Kohnlein O, Dabitz H, Brückt T, Muller N, Pfister H, Lieb R, Mueller JC, Lohmussaar E, Strom TM, Bettecken T, Meitinger T, Uhr M, Rein T, Holsboer F, Muller-Myhsok B. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet. 2004;36(12):1319-1325.
24. Paddock S, Laje G, Chamey D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ. Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort. Am J Psychiatry. 2007;164(8):1181-1188. (Pubitemid 47292406)
25. Kirchheiner J, Lorch R, Lebedeva E, Seeringer A, Roots I, Sasse J, Brockmoller J. Genetic variants in FKBP5 affecting response to antidepressant drug treatment Pharmacogenomics. 2008;9(7):841-846.
26. van Rossum EF, Binder EB, Majer M, Koper JW, lsing M, Modell S, Salyakina D, Lamberts SW, Holsboer F. Polymorphisms of the glucocorticoid receptor gene and major depression. Biol Psychiatry. 2006;59(8):681-688.
27. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, Biggs MM, Shores-Wilson K, Lebowhz BD, RHz L, Niederehe G; STAR*D Investigators Group. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials. 2004;25(1):119142.
28. Hamilton M. A rating scale for depression. JNeurol Neurosurg Psychiatry. 1960; 23:56-62.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
30. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Amow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-1 tern Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psych'ratry. 2003;54(5):573-583. (Pubitemid 37289444)
31. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M; STAR*D Study Team. Evaluation of outcomes with Citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1 ):28-40.
32. McMahon FJ, Buervenich S, Chamey D, Lipsky R, Rush AJ, Wilson AF, SorantAJ, Papanicolaou GJ, Laje G, Fava M, Trivedi MH, Wisniewski SR, Manji H. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment Am J Hum Genet. 2006;78(5):804-814.
33. Fava M, Alpert JE, Carmin CN, Wisniewski SR, Trivedi MH, Biggs MM, ShoresWilson K. Morgan D, Schwartz T, Balasubramani GK, Rush AJ. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med. 2004;34(7):1299-1308. (Pubitemid 39517160)
34. FavaM,RushAJ,AlpertJE,CarminCN,BalasubramaniGK,WisniewskiSR,TrivediMH, BiggsMM,Shores-WilsonK. Whatclinicalandsymptomfeaturesandcomorbiddisorderscharacterizeoutpatientswith anxiousmajordepressivedisorderareplicationandextension.CanJPsychiatry. 2006;51(13):823-835.(Pubitemid46354060)
35. Cassano P, Fava M. Tolerability issues during long-term treatment with antidepressants. Ann Clin Psychiatry. 2004;16(1):15-25. (Pubitemid 40029200)
36. Binder EB, Bradley RG, IJu W, Epstein MP, Deveau TC, Mercer KB, Tang Y, Gillespie CF, Heim CM, Nemeroff CB, Schwartz AC, Cubells JF, Ressler KJ. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA. 2008;299(11):12911305.
37. Bradley RG, Binder EB, Epstein MP, Tang Y, Nair HP, Liu W, Gillespie CF, Berg T, Evces M, Newport DJ, Stowe ZN, Heim CM, Nemeroff CB, Schwartz A, Cubells JF, Ressler KJ. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry. 2008;65(2): 190-200.
38. PritchardJK,StephensM,DonnellyP. Inferenceofpopulationstructureusingmulfjlocusgenotypedata.Genetics.2000;155(2): 945-959.(Pubitemid30397141)
39. Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, lsing M, Holsboer F. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients. Psychoneuroendocrinology. 2009;34(1):99-109.
40. Keck ME, Holsboer F, Muller MB. Mouse mutants for the study of corticotropinreleasing hormone receptor function: development of novel treatment strategies for mood disorders. Ann N Y Acad Sci. 2004;1018:445-457. (Pubitemid 38951439)
41. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res. 1999;33(3):181-214. (Pubitemid 29178663)
42. Nemeroff CB, Vale WW. The neurobiology of depression: inroads to treatment and new drug discovery. J Clin Psychiatry. 2005;66(suppl 7):5-13.
43. Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrine!. 1995;16(4):362-382.
44. Seasholtz AF, Valverde RA, Denver RJ. Corticotropin-releasing hormonebinding protein: biochemistry and function from fishes to mammals. JEndocrinol. 2002;175(1):89-97.
45. PotterE,BehanDP,FischerWH,LintonEA,LowryPJ,ValeWW. CloningandcharacterizationofthecDNAsforhumanandratcorticotropinreleasingfacto rbindingproteins.Nature.1991;349(6308):423-426.(Pubitemid21926104)
46. Boorse GC, Denver RJ. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides. Gen Comp Endocrinol. 2006; 146(1):9-18.
47. Potter E, Behan DP, Linton EA, Lowry PJ, Sawchenko PE, Vale WW. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proč Nati Acad Sci U S A 1992; 89(9):4192-4196.
48. Vitoratos N, Papatheodorou DC, Kalantaridou SN, Mastorakos G. quot;Reproductivequot; corticotropin-releasing hormone. Ann N Y Acad Sci. 2006;1092:310-318.
49. De Luca V, Tharmalingam S, Zai C, Potapova N, Strauss J, Vincent J, Kennedy J. Association of HPA axis genes with suicidal behaviour in schizophrenia. J Psychopharmacol. Published October 6,2008.
50. Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, Kuehn MS, Taylor CM, Neph S, Koch CM, Asthana S, Malhotra A, Adzhubei I, Greenbaum JA, Andrews RM, Flicek P, Boyle PJ, Cao H, Carter NP, Clelland GK, Davis S, Day N, Dhami P, Dillon SC, Dorschner MO, negier H, Giresi PG, Goldy J, Hawrylycz M, Haydock A, Humbert R, James KD, Johnson BE, Johnson EM, Frum TT, Rosenzweig ER, Kamani N, Lee K, Lefebvre GC, Navas PA, Neri F, Parker SC, Sabo PJ, Sandstrom R, Shafer A, Vetrie D, Weaver M, Wilcox S, Yu M, Collins FS, Dekker J, Lieb JD, Tullius TD, Crawford GE, SunyaevS, Noble WS, Dunham I, Denoeud F, Reymond A, Kapranov P, Rozowsky J, Zheng D, Castelo R, Prankish A, Harrow J, Ghosh S, Sandelin A, Hofacker IL, Baertsch R, Keefe D, Dike S, Cheng J, Hirsch HA, Sekinger EA, Lagarde J, Abril JF, Shahab A, Flamm C, Fried C, Hackermüller J, Hertel J, Lindemeyer M, Missal K, Tanzer A, Washietl S, Korbel J, Emanuelsson O, Pedersen JS, Holroyd N, Taylor R, Swarbreck D, Matthews N, Dickson MC, Thomas DJ, Weirauch MT, Gilbert J, Drenkow J, Bell I, Zhao X, Srinivasan KG, Sung WK, Ooi HS, Chiu KP, Foissac S, Alioto T, Brent M, Pachter L, Tress ML, Valencia A, Choo SW, Choo CY, UcIa C, Manzano C, Wyss C, Cheung E, Clark TG, Brown JB, Ganesh M, Patel S, Tammana H, Chrast J, Henrichsen CN, Kai C, Kawai J, Nagalakshmi U, Wu J, Lian Z, Lian J, Newburger P, Zhang X, Bickel P, Maffick JS, Caminci P, Hayashizaki Y, Weissman S, Hubbard T, Myers RM, Rogers J, Stadler PF, Lowe TM, Wei CL, Ruan Y, Struhl K, Gerstein M, Antonarakis SE, Fu Y, Green ED, Karaoz U, Siepel A, Taylor J, Liefer LA, Wetterstrand KA, Good PJ, Feingold EA, Guyer MS, Cooper GM, Asimenos G, Dewey CN, Hou M, Nikolaev S, Montoya-Burgos Jl, Loytynoja A, Whelan S, Pardi F, Massingham T, Huang H, Zhang NR, Holmes I, Mullikin JC, Ureta-Vidal A, Paten B, Seringhaus M, Church D, Rosenbloom K, Kent WJ, Stone EA, Batzoglou S, Goldman N, Haralson RC, Haussler D, Miller W, Sidow A, Trinklein ND, Zhang ZD, Barrera L, Stuart R, King DC, Ameur A, Enroth S, Bieda MC, Kim J, Bhinge AA, Jiang N, Liu J, Yao F, Vega VB, Lee CW, Ng P, Shahab A, Yang A, Moqtaderi Z, Zhu Z, Xu X, Squazzo S, Oberley MJ, lnman D, Singer MA, Richmond TA, Munn KJ, Rada-lglesias A, Wallerman O, Komorowski J, Fowler JC, Couttet P, Bruce AW, Dovey OM, Ellis PD, Langford CF, Nix DA, Euskirchen G, Hartman S, Urban AE, Kraus P, Van Calcar S, Heintzman N, Kim TH, Wang K, Qu C, Hon G, Luna R, Glass CK, Rosenfeld MG, Aldred SF, Cooper SJ, Hatees A, Lin JM, Shulha HP, Zhang X, Xu M, Haidar JN, Yu Y, Ruan Y, Iyer VR, Green RD, Wadelius C, Famham PJ, Ren B, Harte RA, Hinrichs AS, Trumbower H, Clawson H, HillmanJackson J, Zweig AS, Smith K, Thakkapallayil A, Barber G, Kuhn RM, Karolchik D, Armengol L, Bird CP, de Bakker Pl, Kern AD, Lopez-Bigas N, Martin JD, Stranger BE, Woodroffe A, Davydov E, Dimas A, Eyras E, Hallgrímsdottir IB, Huppert J, Zody MC, Abecasis GR, Estivill X, Bouffard GG, Guan X, Hansen NF, Idol JR, Maduro W, Maskeri B, McDowell JC, Park M, Thomas PJ, Young AC, Blakesley RW, Muzny DM, Sodergren E, Wheeler DA, Worley KC, Jiang H, Weinstock GM, Gibbs RA, Graves T, Fulton R, Mardis ER, Wilson RK, Clamp M, Cuff J, Gnerre S, Jaffe DB, Chang JL, Lindblad-Toh K, Lander ES, Koriabine M, Nefedov M, Osoegawa K, YoshinagaY, Zhu B, de Jong PJ; ENCODE Project Consortium; NISC Comparative Sequencing Program; Baylor College of Medicine Human Genome Sequencing Center; Washington University Genome Sequencing Center Broad Institute; Children's Hospital Oakland Research Institute. Identification and analysis of functional elements in 1 % of the human genome by the ENCODE pilot project Nature. 2007;447(7146):799-816.
51. Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch S, LyIe R, Hunt S, Kahl B, Antonarakis SE, Tavare S, Deloukas P,Dermitzakis ET. Genome-wide associations of gene expression variation in humans. PLoS Genet 2005;1 (6): e78.